Pear Therapeutics
As the first prescription digital therapeutic approved by the FDA, the treatment will be distributed and supported by a specialist-staffed service center.
The definition is broad, but an accompanying whitepaper attempts to pin down the category's place in the industry.
A collaborative attitude and a commitment to strenuous review have characterized the process so far.
At the Digital Health Innovation Summit in Boston, experts said early digital therapeutics companies have an opportunity to sculpt the space.